Micol Ravà

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination”.

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination

Nature Immunology(2024)10.1038/s41590-024-01787-z

N/A

0.606DataRank · unranked

56 citations

Micol Ravà, Davide Marotta, Pietro Di Lucia, Elisa Bono, Leonardo Giustini +20 more

Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.12.452027

N/A

0DataRank · unranked

3 citations

Michele Tomasi, Cinzia Bertelli, Teresa Vanzo, Assunta Gagliardi, Elena Caproni +19 more

Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine

Vaccines(2023)10.3390/vaccines11101546

N/A

0DataRank · unranked

11 citations

Michele Tomasi, Irfan Ullah, Cinzia Bertelli, Teresa Vanzo, Silvia Accordini +22 more

Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine

Research Square(2023)10.21203/rs.3.rs-2788726/v1

N/A

0DataRank · unranked

5 citations

Michele Tomasi, Irfan Ullah, Cinzia Bertelli, Teresa Vanzo, Silvia Accordini +22 more

Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells

JHEP Reports(2024)10.1016/j.jhepr.2024.101038

N/A

0DataRank · unranked

7 citations

Sarah L. Draper, Olivia K. Burn, R. J. Anderson, Benjamin J. Compton, Ching‐Wen Tang +18 more